News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,296 Results
Type
Article (40032)
Company Profile (188)
Press Release (664076)
Section
Business (209292)
Career Advice (1928)
Deals (35021)
Drug Delivery (107)
Drug Development (79357)
Employer Resources (149)
FDA (15854)
Job Trends (15279)
News (347370)
Policy (32778)
Tag
Academia (2720)
Alliances (46133)
Alzheimer's disease (1371)
Approvals (15821)
Artificial intelligence (237)
Bankruptcy (327)
Best Places to Work (12326)
Biotechnology (135)
Breast cancer (243)
Cancer (1833)
Cardiovascular disease (147)
Career advice (1555)
CAR-T (132)
Cell therapy (394)
Clinical research (63987)
Collaboration (714)
Compensation (382)
COVID-19 (2374)
C-suite (175)
Data (1673)
Diabetes (226)
Diagnostics (6719)
Earnings (94511)
Events (122641)
Executive appointments (599)
FDA (16806)
Funding (642)
Gene therapy (274)
GLP-1 (716)
Government (4775)
Healthcare (20565)
Infectious disease (2499)
Inflammatory bowel disease (134)
Interviews (324)
IPO (17020)
Job creations (3411)
Job search strategy (1373)
Layoffs (482)
Legal (7672)
Lung cancer (271)
Manufacturing (263)
Medical device (14265)
Medtech (14270)
Mergers & acquisitions (18445)
Metabolic disorders (603)
Neuroscience (1813)
NextGen: Class of 2025 (7084)
Non-profit (5012)
Northern California (2148)
Obesity (339)
Opinion (209)
Patents (172)
People (56129)
Phase I (19980)
Phase II (28365)
Phase III (21265)
Pipeline (737)
Postmarket research (2194)
Preclinical (8335)
Radiopharmaceuticals (261)
Rare diseases (352)
Real estate (5716)
Regulatory (22145)
Research institute (2434)
Resumes & cover letters (339)
Southern California (1846)
Startups (3318)
United States (19219)
Vaccines (616)
Weight loss (246)
Date
Today (11)
Last 7 days (691)
Last 30 days (2773)
Last 365 days (36560)
2025 (4904)
2024 (37313)
2023 (42382)
2022 (53016)
2021 (57342)
2020 (56695)
2019 (50584)
2018 (37410)
2017 (33678)
2016 (33120)
2015 (38525)
2014 (31629)
2013 (26798)
2012 (28035)
2011 (28758)
2010 (25653)
Location
Africa (728)
Arizona (175)
Asia (41823)
Australia (6856)
California (4875)
Canada (1744)
China (415)
Colorado (225)
Connecticut (246)
Europe (93416)
Florida (708)
Georgia (174)
Illinois (488)
Indiana (274)
Japan (125)
Maryland (794)
Massachusetts (3790)
Michigan (217)
Minnesota (354)
New Jersey (1397)
New York (1394)
North Carolina (936)
Northern California (2148)
Ohio (184)
Pennsylvania (1115)
South America (1123)
Southern California (1846)
Texas (718)
Utah (151)
Washington State (487)
704,296 Results for "20 20 bioresponse".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight Loss
‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss
With Amgen’s MariTide results at the lower end of investors’ expectation of 20% to 25% weight loss, the much-anticipated readout sent the company’s shares tumbling.
November 26, 2024
·
2 min read
·
Annalee Armstrong
Business
Seaport, With 20/20 Hindsight, Takes Lessons From Neuropsych’s Stumbles
Amidst a “renaissance” of interest in neuropsychiatry, Seaport’s executive team is taking nothing for granted.
January 15, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Bruker Corporation to Present at Upcoming Investor Conferences - February 20, 2025
February 21, 2025
·
1 min read
Multiple sclerosis
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis
New research has found that MS patients treated with anti-CD20 antibodies, such as Roche’s Ocrevus, do not experience significantly slower progression of disability.
September 26, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Immunoassay Market Size Expected to Hit USD 56.20 Billion by 2034
February 20, 2025
·
1 min read
Press Releases
Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn’s and Colitis Organisation
February 19, 2025
·
5 min read
Press Releases
FDA Roundup: December 20, 2024
December 23, 2024
·
7 min read
Press Releases
Lynx Dx Introduces At-Home Collection Option for MyProstateScore 2.0
February 4, 2025
·
5 min read
Press Releases
Rockwell Medical to Release Fourth Quarter and Full-Year 2024 Results on Thursday, March 20, 2025
February 20, 2025
·
1 min read
Press Releases
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
February 14, 2025
·
1 min read
1 of 70,430
Next
